An ex vivo evaluation of regulatory role of biogenic amines in rat seminal vesicle after pharmacological manipulation

Life Sciences

Volumn 63, Issue 15, 1998, Pages PL221-PL229

  Hsieh, Ju Ton ^a   Liu, Shih Ping ^a   Hsieh, Cheng Hsing ^a   Lai, Ming Kuan ^a   Cheng, Juei Tang ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Biogenic amines; Electric stimulation; Lesser splanchnic nerve; Neuroregulation; Rat seminal vesicle

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; CATECHOLAMINE; DOPAMINE; HOMOVANILLIC ACID; NEUROTOXIN; NORADRENALIN; OXIDOPAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; EJACULATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NEUROMODULATION; NONHUMAN; RAT; SEMINAL VESICLE; SEROTONINERGIC NERVE; SPINAL CORD; SPLANCHNIC NERVE;

EID: 0032483239     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00403-2     Document Type: Article

References (22)

1. 1. J.S. FEDAN, J.C. BESSE, F.G. CARPENTER and R. TEAGUE, J. Pharmacol. Exp. Ther. 201 285-297 (1977).
2. 2. C.H. OWMAN and N.O. SJOBERG, J. Reprod. Pert. 28 379-387 (1972).
3. 3. M. STJERNQUIST, C.H. OWMAN, N.O. SJOBERG and F. SUNDLER, Biol. Reprod. 36 149-155 (1987).
4. 4. Y. KIMURA, N. KISAKI, S. SAKURADA and T. TADANO, Andrologia 8 313-320 (1976).
5. 5. Y. KIMURA, N. KISAKI, S. SAKURADA and T. TADANO, Andrologia 9 50-54 (1977).
6. 6. L. NEGRI, G.F. ERAPAMER and D. PICCINELLI, Arch. Int. Pharmacodyn. 205 23-28 (1973).
7. 7. S.I. SHARIF and S.D. GAKHALE, J. Pharmacol. Methods 15 65-75 (1986).
8. 8. G. BERRETA, E. CHELO, F. FANCIULACCI and A. ZANOLLO, Acta. Eur. Fertil. 17 43-45 (1986).
9. 9. M. SHILON, G.F. PAZ and Z.T. HOMONNAI, Fertil. Steril. 42 659-661 (1984).
10. 10. S.E. ALTHOF, S.B. LEVINE, E.W. CORTY, C.B. RISEN, E.B. STERN and D.M. KURIT, J. Clin. Psychiat. 56 402-407 (1995).
11. 11. R.T. SEGRAVES, A. SARAN, K. SEGRAVES and E. MAGUIRE, J. Sex & Marital Ther. 19 198-200 (1993).
12. 12. R. FAVRE, M. DE HAUT, Y. DALMAZ, J.M. PEQUIGNOT and L. PEYRIN, Neural. Transm. 66 135-149 (1986).
13. 13. D. AMENTA, C. CAVALLOTTI, M. DE ROSSI, F. FERRANTE and F. AMENTA, FUNCT. Neurol. 2 207-216 (1987).
14. 14. J.T. HSIEH, C.T. CHIEN, S.P. LIU, C.F. CHEN and M.K. LAI, Neurosci. Lett. 204 215-217 (1996).
15. 15. G. JONSSON, H. HALLMAN, F. PONZIO and S. ROSS, Europ. J. Pharmacol. 72 173-188 (1981).
16. 16. T. NAKAZAWA, Y. YAMANISHI and T. KANEKO, J. Pharmacol. Exp. Ther. 25 748-753 (1991).
17. 17. U. UNGERSTEDT, Europ. J. Pharmacol. 5 107-110 (1968).
18. 18. L. M. BROWN, D.L. SMITH, G.M. WILLIAMS and D.J. SMITH, Neurosci. Lett. 102 103 (1989).
19. 19. J.T. CHENG, C.L. SHEN and J.J. HUANG, Res. Exp. Med. 190 315-322 (1990).
20. 20. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR and R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
21. 21. T.A. READER and P. GAUTHIER, J. Neural. Transmission. 59 207-227 (1984).
22. 22. L. MARSON and K.E. MCKENNA, Exp. Brain. Res. 88 313-320 (1992).